AXON
Price
$760.90
Change
+$4.77 (+0.63%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
59.73B
52 days until earnings call
GMAB
Price
$27.98
Change
+$0.17 (+0.61%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
17.42B
52 days until earnings call
Interact to see
Advertisement

AXON vs GMAB

Header iconAXON vs GMAB Comparison
Open Charts AXON vs GMABBanner chart's image
Axon Enterprise
Price$760.90
Change+$4.77 (+0.63%)
Volume$2.01K
Capitalization59.73B
Genmab A/S ADS
Price$27.98
Change+$0.17 (+0.61%)
Volume$42.57K
Capitalization17.42B
AXON vs GMAB Comparison Chart in %
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. GMAB commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and GMAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (AXON: $756.13 vs. GMAB: $27.82)
Brand notoriety: AXON and GMAB are both not notable
AXON represents the Aerospace & Defense, while GMAB is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 48% vs. GMAB: 119%
Market capitalization -- AXON: $59.73B vs. GMAB: $17.42B
AXON [@Aerospace & Defense] is valued at $59.73B. GMAB’s [@Biotechnology] market capitalization is $17.42B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $304.11B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $22.59B. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 2 FA rating(s) are green whileGMAB’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 2 green, 3 red.
  • GMAB’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than GMAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while GMAB’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 6 bearish.
  • GMAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GMAB is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а +3.81% price change this week, while GMAB (@Biotechnology) price change was +1.02% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +4.49%. For the same industry, the average monthly price growth was +4.06%, and the average quarterly price growth was +45.38%.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.74%. For the same industry, the average monthly price growth was +7.59%, and the average quarterly price growth was +34.47%.

Reported Earning Dates

AXON is expected to report earnings on Nov 06, 2025.

GMAB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Aerospace & Defense (+4.49% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($59.7B) has a higher market cap than GMAB($17.4B). AXON has higher P/E ratio than GMAB: AXON (187.39) vs GMAB (14.39). GMAB YTD gains are higher at: 33.301 vs. AXON (27.226). GMAB has higher annual earnings (EBITDA): 1.48B vs. AXON (341M). GMAB has more cash in the bank: 2.9B vs. AXON (2.23B). GMAB has less debt than AXON: GMAB (148M) vs AXON (2.05B). GMAB has higher revenues than AXON: GMAB (3.26B) vs AXON (2.39B).
AXONGMABAXON / GMAB
Capitalization59.7B17.4B343%
EBITDA341M1.48B23%
Gain YTD27.22633.30182%
P/E Ratio187.3914.391,302%
Revenue2.39B3.26B73%
Total Cash2.23B2.9B77%
Total Debt2.05B148M1,386%
FUNDAMENTALS RATINGS
AXON vs GMAB: Fundamental Ratings
AXON
GMAB
OUTLOOK RATING
1..100
1946
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
9100
SMR RATING
1..100
5738
PRICE GROWTH RATING
1..100
4341
P/E GROWTH RATING
1..100
1186
SEASONALITY SCORE
1..100
8511

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GMAB's Valuation (59) in the null industry is in the same range as AXON (91) in the Biotechnology industry. This means that GMAB’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (9) in the Biotechnology industry is significantly better than the same rating for GMAB (100) in the null industry. This means that AXON’s stock grew significantly faster than GMAB’s over the last 12 months.

GMAB's SMR Rating (38) in the null industry is in the same range as AXON (57) in the Biotechnology industry. This means that GMAB’s stock grew similarly to AXON’s over the last 12 months.

GMAB's Price Growth Rating (41) in the null industry is in the same range as AXON (43) in the Biotechnology industry. This means that GMAB’s stock grew similarly to AXON’s over the last 12 months.

AXON's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for GMAB (86) in the null industry. This means that AXON’s stock grew significantly faster than GMAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONGMAB
RSI
ODDS (%)
Bearish Trend 6 days ago
58%
Bearish Trend 4 days ago
51%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
64%
Momentum
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
63%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 11 days ago
63%
Declines
ODDS (%)
Bearish Trend 13 days ago
66%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
67%
Aroon
ODDS (%)
Bearish Trend 4 days ago
48%
Bullish Trend 4 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AMZD10.480.09
+0.82%
Direxion Daily AMZN Bear 1X ETF
BST40.880.17
+0.42%
BlackRock Science and Technology Trust
IBHJ26.68-0.02
-0.07%
iShares iBonds 2030 Term Hi Yld & IncETF
RFI12.02-0.01
-0.08%
Cohen and Steers Total Return Realty Fund
CAFX25.17-0.03
-0.12%
Congress Intermediate Bond ETF

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+0.67%
TECH - AXON
61%
Loosely correlated
-3.66%
VCYT - AXON
58%
Loosely correlated
-3.08%
BEAM - AXON
57%
Loosely correlated
-4.41%
SEER - AXON
56%
Loosely correlated
-0.49%
ADPT - AXON
56%
Loosely correlated
-6.52%
More

GMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with GNMSF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then GNMSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMAB
1D Price
Change %
GMAB100%
-2.76%
GNMSF - GMAB
58%
Loosely correlated
N/A
AXON - GMAB
47%
Loosely correlated
+0.67%
TECH - GMAB
39%
Loosely correlated
-3.66%
ARVN - GMAB
37%
Loosely correlated
-0.90%
IPSC - GMAB
36%
Loosely correlated
-3.38%
More